Skip to content

Changes in quality of life through the early intervention by palliative care team for patients with advanced lung cancer

Changes in quality of life through the early intervention by palliative care team for patients with advanced lung cancer - Changes in quality of life through the early intervention by palliative care team for patients with advanced lung cancer

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000012932
Enrollment
40
Registered
2014-01-25
Start date
2011-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

The attending physician will follow-up items of two points from 1 with OPTIM published&quot
STEP palliative care&quot
. Attending physician to perform the consultation the PCT if the patient&#39
s symptoms were exacerbated. Palliative care team to follow-up items four points from three. Patients make an appointment with the palliative physician, Palliative physician to determine the contents

Sponsors

Yokohama Municipal Citizen Hospital Department of Palliative Medicine
Lead Sponsor
Yokohama Municipal Citizens Hospital Department of Respiratory Palliative Medicine Yokohama Municipal Citizens Hospital Department of Medical Oncology Medicine
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients 20 years old or more. 2.Newly diagnosed patients with stage 4 lung cancer. 3.PS of Eastern Cooperative Oncology Group is 0 to 3. 4.Patients can be expected survival of more than a month.

Exclusion criteria

Exclusion criteria: 1.There is a depression at the start of the test time is patient. 2. It is not possible for the patient to understand Japanese. 3.Patient is not able to visit once a month to our hospital. 4.If the attending physician was deemed inappropriate to participate in the study.

Design outcomes

Primary

MeasureTime frame
The primary endpoint is the difference between the QOL that was assessed by the EORTC QLQ c-15-PAL after 12 weeks after the start of the test and at the beginning of the study.

Secondary

MeasureTime frame
Secondary endpoint is the change of each QOL item and an evaluation of QOL by the patients was compared with its estimation by the attending physicians.

Countries

Japan

Contacts

Public ContactTaro Yokoyama

Yokohama Municipal Citizen Hospital Department of Palliative Medicine

taroman045@gmail.com045-331-1961

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026